SELL and melanoma: It is interesting to note that, in the case of ex vivo cultured murine lymphocytes used for adoptive immunotherapy to treat B16 melanoma, extended culture periods result in loss of CD62L expression and this is correlated with decreased effectiveness in vivo[50].